Edwards Lifesciences Corp (NYSE:EW)
February 12th, 2019
With markets going up Edwards Lifesciences Corp went up $4.28 Tuesday which equals a 2.47% increase, closing at $177.59. Furthermore it hit a new 52 week high of $178.39.
Edwards Lifesciences Corp is listed on the S&P 500 index, and was one of 405 stocks that increased today. Weighted by market cap, EW represents about 0.15% of the S&P 500.
Forecasts from 21 analysts suggest that Edwards Lifesciences Corp might fall somewhat (-3.49%), while Finbox has calculated (with low uncertainty) a fair value price of $125.75.
The market sectors were mixed Tuesday with a majority of the sectors trending up. Materials saw the biggest increase of the day (2.25%), while Real Estate saw the biggest drop (-0.70%). Industrials has seen the biggest year-to-date gain at 13.91%.
Materials saw the biggest turnaround from its 5-day performance of -1.14%, as it went up 2.25%. Real Estate saw a turn around from its 5-day performance of 0.96% trading down -0.70%.
- Materials went up with a 2.25% change.
- Consumer Discretionary went up with a 1.66% change.
- Industrials went up with a 1.56% change.
- Financials went up with a 1.56% change.
- Information Technology went up with a 1.36% change.
- Healthcare went up with a 1.34% change.
- Energy went up with a 1.18% change.
- Communication Services went up with a 1.14% change.
- Consumer Staples went up with a 0.88% change.
- Utilities went up with a 0.17% change.
- Real Estate went down with a -0.70% change.
Edwards Lifesciences Corp Info
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and related delivery systems for the nonsurgical replacement of heart valves. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings and the beating-heart mitral repair systems; and cardiac cannula devices, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function in surgical and intensive care settings; pulmonary artery catheters; Oximetry Central Venous catheters, as well as clinical monitoring platforms that display a patient’s physiological status; and disposable pressure monitoring devices and closed blood sampling systems to protect patients and clinicians from infection. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.